Saturday, April 25, 2009: 12:30 PM-2:00 PM
Session Organizer:
Emma Webb, ACCP
Rebound in thrombotic potential while on clopidogrel therapy
Nicholas B. Norgard, Pharm.D., University at Buffalo- School of Pharmacy and Pharmaceutical Science;
Shoaib Saya, M.D., University of Oklahoma Health Sciences Center, Department of Medicine;
Eliot Schechter, M.D., University of Oklahoma Health Sciences Center, Department of Medicine;
George L. Dale, Ph.D., University of Oklahoma Health Sciences Center, Department of Medicine
Evaluation of blood glucose control with subcutaneous insulin in patients with recent critical illness
April D. Miller, PharmD, South Carolina College of Pharmacy-USC Campus;
Leslie McKenzie, PharmD Candidate, South Carolina College of Pharmacy-USC Campus;
Richard M. Schulz, PhD, South Carolina College of Pharmacy-USC Campus;
P. Brandon Bookstaver, PharmD, South Carolina College of Pharmacy-USC Campus;
Celeste N. Rudisill, PharmD, South Carolina College of Pharmacy-USC Campus
Is high dose statin therapy safe in the elderly ?
Séverine Gupta, PharmD, APHP Hôpital Charles Foix - Department of Pharmacy;
Isabelle Peyron, PharmD, APHP Hôpital Charles Foix - Department of Pharmacy;
Christelle Laguillier, PharmD, APHP Hôpital Charles Foix - Department of Clinical Chemistry;
Nadine Oboa, PharmD, APHP Hôpital Charles Foix - Department of Pharmacy;
Anna Sarfati, PharmD, APHP Hôpital Charles Foix - Department of Pharmacy
Retrospective comparison of bivalirudin and argatroban in the management of heparin-induced thrombocytopenia
Lee P. Skrupky, PharmD, Barnes-Jewish Hospital;
Jennifer R. Smith, PharmD, Barnes-Jewish Hospital;
Heather Arnold, PharmD, Barnes-Jewish Hospital;
Eli N. Deal, Pharm.D., Barnes-Jewish Hospital;
James M. Hollands, PharmD, Barnes-Jewish Hospital;
Emily J. Martinez, PharmD, Barnes-Jewish Hospital;
Scott T. Micek, PharmD, Barnes-Jewish Hospital
Drug use evaluation of prothrombin complex concentrate (Factor IX complex concentrated)
Luis Mendarte, PHARM, D, HOSPITAL UNIVERSITARY VALL D'HEBRON;
Marta Munne, Pharm D, HOSPITAL UNIVERSITARY VALL D'HEBRON;
Francesc X Nuvials, Phys D, HOSPITAL UNIVERSITARY VALL D'HEBRON;
Jessika Gomez-lopez, Technician, HOSPITAL UNIVERSITARY VALL D'HEBRON;
Jose B. Montoro, Ph D, HOSPITAL UNIVERSITARY VALL D'HEBRON;
Jose Monterde, Ph D, HOSPITAL UNIVERSITARY VALL D'HEBRON
Venous Thromboembolism Prophylaxis Study in hospitalized non-surgical Patients
Petra Jancar, mag.pharm, University Clinic Golnik;
Tina Morgan, mag.pharm, University Clinic Golnik;
Ales Mrhar, mag.pharm, Faculty of pharmacy, University of Ljubljana;
Mitja Kosnik, dr.med.spec, University Clinic Golnik;
Mitja Lainscak, dr.med.spec, Faculty of pharmacy, University of Ljubljana
Renal dysfunction is associated with reduced warfarin maintenance dose and increased INR instability
Megan E. Kleinow, PharmD, Detroit Medical Center;
Jennifer L. Clemente, PharmD, Detroit Medical Center;
Candice L. Garwood, PharmD, Wayne State University, Department of Pharmacy Practice;
Peter Whittaker, PhD, Wayne State University School of Medicine, Cardiovascular Research Institute and Dept of Emergency Medicine
Comparison of intravenous and subcutaneous heparin conversion methods
Avinash S. Patil, MD, Department of Obstetrics & Gynecology, University of Tennessee Health Science Center;
Tracy Clapp, Pharm.D., Department of Pharmacy, The Regional Medical Center at Memphis;
Kan Gaston, Pharm.D., Department of Pharmacy, The Regional Medical Center at Memphis;
David Kuhl, Pharm.D., School of Pharmacy, Union Universty;
Eliza Rinehart, Pharm.D., Department of Pharmacy, The Regional Medical Center at Memphis;
Norman L. Meyer, M.D., Department of Obstetrics & Gynecology, University of Tennessee Health Science Center
Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam, administered by prolonged infusion, in hospitalized patients
Katherine M. Shea, Pharm.D., Clarian Health Partners, Inc., Methodist Hospital;
S. Christian Cheatham, Pharm.D., St. Francis Hospitals and Health Centers;
David W. Smith, Pharm.D., Clarian Health Partners, Inc., Methodist Hospital;
Matthew F. Wack, M.D., Infectious Diseases of Indiana;
Kevin M. Sowinski, Pharm.D., Purdue University School of Pharmacy;
Michael B. Kays, Pharm.D., Purdue University School of Pharmacy
Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using pharmacokinetic data from hospitalized patients
Katherine M. Shea, Pharm.D., Clarian Health Partners, Inc., Methodist Hospital;
S. Christian Cheatham, Pharm.D., St. Francis Hospitals and Health Centers;
Matthew F. Wack, M.D., Infectious Diseases of Indiana;
David W. Smith, Pharm.D., Clarian Health Partners, Inc., Methodist Hospital;
Kevin M. Sowinski, Pharm.D., Purdue University School of Pharmacy;
Michael B. Kays, Pharm.D., Purdue University School of Pharmacy
Cefepime is not associated with increased mortality in pediatric cancer patients
Jamie Frediani, BS, St. Jude Children's Research Hospital;
Elisabeth E. Adderson, MD, St. Jude Children's Research Hospital;
Patricia Flynn, MD, MS, St. Jude Children's Research Hospital;
Michael J. Herr, BS, St. Jude Children's Research Hospital;
James M. Hoffman, Pharm.D., M.S., BCPS, St. Jude Children's Research Hospital
Factors Influencing Pharmacists' Perceived Knowledge of Pediatric Topics
Paul J. Munzenberger, M.S., Pharm.D., Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University;
Victoria Tutag Lehr, Pharm.D., Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University;
Stephanie Baringhaus, Pharm.D., Wayne State University;
Ronald Thomas, Ph.D., Department of Pediatrics, Children's Hospital of Michigan
![[ Visit Client Website ]](images/banner.gif)